No oncogenes or tumor suppressor genes (defined in the Cancer Gene Census [CGC]) beyond TP53 had frequent nonsilent single nucleotide variants (SNVs) or insertions and deletions (indels) across the cancers (Figure 2A; the most frequent mutations in general are shown in Supplemental Figure 8). This evidence concerns the gene TP53 and cancer.